152436-73-2

Basic information

• Product Name: 6,7-Dimethoxy-2-(3-nitro-benzyl)-1,2,3,4-tetrahydro-isoquinoline
• Synonyms: 6,7-Dimethoxy-2-(3-nitro-benzyl)-1,2,3,4-tetrahydro-isoquinoline
• CAS NO: 152436-73-2
• Molecular Weight: 328.368
• Mol File: 152436-73-2.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 6,7-Dimethoxy-2-(3-nitro-benzyl)-1,2,3,4-tetrahydro-isoquinoline(CAS DataBase Reference)
• NIST Chemistry Reference: 6,7-Dimethoxy-2-(3-nitro-benzyl)-1,2,3,4-tetrahydro-isoquinoline(152436-73-2)
• EPA Substance Registry System: 6,7-Dimethoxy-2-(3-nitro-benzyl)-1,2,3,4-tetrahydro-isoquinoline(152436-73-2)

Safety Data

• Hazardous Substances Data: 152436-73-2(Hazardous Substances Data)

Upstream product

• 1745-07-9 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline 
• 99-61-6 3-nitro-benzaldehyde 
• 99-08-1 1-methyl-3-nitrobenzene 
• 3958-57-4 1-bromomethyl-3-nitrobenzene 

Relevant articles and documents

Aromatic-ring azacyclo derivatives and application thereof

Aromatic-ring azacyclo derivatives and an application thereof are provided. The invention relates to compounds represented by the formula (V), and a preparation method and an application thereof in medicines. In particular, the invention relates to derivatives of the compounds represented by the general formula (V), and a preparation method and the application thereof as therapeutic agents in prevention and treatment of hyperlipidemia, hypercholesterolemia, hypertriglyceridemia, hepatic steatosis, type-II diabetes, hyperglycemia, obesity or insulin resistance syndromes and metabolic syndromes. The compounds disclosed by the invention also can reduce total cholesterol, LDL-cholesterol and triglycerides, increase the expression of hepatic LDL receptors and inhibit the expression of PCSK9.